Gentis news

Trends and applications of AI and omics data in genetic testing and reproductive genetic counseling

In recent years, artificial intelligence (AI) has emerged as one of the key driving forces behind the technological revolution across many fields, especially healthcare. From medical imaging diagnostics and chronic disease management to drug research and development, AI has demonstrated its pivotal role in improving treatment effectiveness and personalizing healthcare. In the field of genetics and assisted reproduction, the integration of AI, bioinformatics, and Omics data is expected to create major breakthroughs, significantly enhancing the quality of screening, diagnosis, and genetic counseling.

Warning of fraudulent impersonation of Eurofins GENTIS requesting customers to transfer money for early delivery of test results

Dear Valued customers and partners,

Eurofins GENTIS honored to participate in the reproductive genetics & PGT conference 2026

On January 18, 2026, at New World Saigon Hotel, Ho Chi Minh City, the Ho Chi Minh City Society of Reproductive Endocrinology & Infertility (HOSREM) – one of the most reputable professional organizations in reproductive medicine in Vietnam – in collaboration with specialized partners, will organize the Reproductive Genetics & PGT Conference.

Eurofins GENTIS launches GEN28 – carrier screening test for 28 recessive genetic disorders

On the journey of parenthood, nothing is more important than ensuring a child is born healthy. In reality, many individuals who appear completely healthy may unknowingly carry recessive genetic mutations. When both partners carry the same recessive gene, the risk of having a child affected by serious genetic disorders can be as high as 25%, leading to long-term impacts on health and quality of life.

Congratulations on the successful December prenatal class – The journey to happy motherhood of Andrology and Fertility hospital of Hanoi

On the morning of December 27, 2025, at the 5th Floor Hall – Building A, Andrology and Fertility hospital of Hanoi, the program “Prenatal Class – The Journey to Happy Motherhood” was successfully held, leaving many deep emotions and meaningful values for all expectant mothers and their families in attendance. The program was not only a simple medical knowledge-sharing session but also a journey of spreading love, understanding, and strong faith for families preparing to welcome their little angels.

Eurofins GENTIS & andrology and fertility hospital of Hanoi announce research on recurrent pregnancy loss: The role of multigene sequencing in genetic screening and counseling

Recently, the scientific study entitled “Recurrent Pregnancy Loss: The Role of Multigene Sequencing in Genetic Screening and Counseling,” conducted by Eurofins GENTIS and the Hanoi Hospital of Andrology and Infertility, was officially published in Issue No. 197 of the Journal of Medical Research.

Eurofins GENTIS & Andrology and fertility hospital of Hanoi publish research findings on recurrent pregnancy loss in the journal of medical research

Recently, Eurofins GENTIS and the Hanoi Hospital of Andrology and Infertility officially published the results of their scientific study evaluating the role of multigene sequencing (NGS) — specifically the FertiScan™ panel — in identifying genetic causes in women with a history of recurrent pregnancy loss (RPL).

Eurofins GENTIS pioneers the deployment of Next-Generation sequencing technology MiSeq i100 Plus in Vietnam

Eurofins GENTIS has officially marked a major milestone by becoming the first organization in Vietnam to install and deploy the MiSeq i100 Plus system — the latest next-generation sequencing (NGS) technology from Illumina. This achievement strongly affirms Eurofins GENTIS’s long-term commitment to continuously advancing genetic diagnostic capabilities and aligning with the highest standards of modern global medicine.